BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9135545)

  • 21. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
    Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U
    Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice.
    Kneitz B; Herrmann T; Yonehara S; Schimpl A
    Eur J Immunol; 1995 Sep; 25(9):2572-7. PubMed ID: 7589128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo.
    Sundstedt A; Höiden I; Rosendahl A; Kalland T; van Rooijen N; Dohlsten M
    J Immunol; 1997 Jan; 158(1):180-6. PubMed ID: 8977189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further clonal expansion of T cells upon rechallenge of superantigen staphylococcal enterotoxin A.
    Aoki Y; Yoshikai Y
    Microbiol Immunol; 1997; 41(4):337-43. PubMed ID: 9159408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism underlying superantigen-induced clonal deletion of mature T lymphocytes.
    Biasi G; Panozzo M; Pertile P; Mezzalira S; Facchinetti A
    Int Immunol; 1994 Jul; 6(7):983-9. PubMed ID: 7947466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship.
    Miethke T; Wahl C; Gaus H; Heeg K; Wagner H
    Eur J Immunol; 1994 Aug; 24(8):1893-902. PubMed ID: 8056049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection.
    Aoki Y; Hiromatsu K; Usami J; Makino M; Igarashi H; Ogasawara J; Nagata S; Yoshikai Y
    J Immunol; 1994 Oct; 153(8):3611-21. PubMed ID: 7523498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
    Lane P; Haller C; McConnell F
    Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC).
    Vingerhoets J; Dohlsten M; Penne G; Colebunders R; Sansom D; Bosmans E; Kestens L; Vanham G
    Clin Exp Immunol; 1998 Jan; 111(1):12-9. PubMed ID: 9472656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma.
    Cauley LS; Miller EE; Yen M; Swain SL
    J Immunol; 2000 Dec; 165(11):6056-66. PubMed ID: 11086037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-modulation of CD2 delays deletion of superantigen-responsive T cells.
    Fortner KA; Russell JQ; Budd RC
    Eur J Immunol; 1998 Jan; 28(1):70-9. PubMed ID: 9485187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
    Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X
    Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-gamma and interleukin-10 secretion.
    Florquin S; Amraoui Z; Goldman M
    Eur J Immunol; 1995 May; 25(5):1148-53. PubMed ID: 7774618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
    Sabapathy TK; Hwang LA; Hui KM
    Cell Immunol; 1994 Oct; 158(1):83-95. PubMed ID: 7916268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTL hyporesponsiveness induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis.
    Prell RA; Dearstyne E; Steppan LG; Vella AT; Kerkvliet NI
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):214-21. PubMed ID: 10906285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.
    Sundstedt A; Sigvardsson M; Leanderson T; Hedlund G; Kalland T; Dohlsten M
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):979-84. PubMed ID: 8577772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of unresponsiveness to the superantigen staphylococcal enterotoxin B: cyclosporin A resistant split unresponsiveness unfolds in vivo without preceding clonal expansion.
    Heeg K; Bendigs S; Miethke T; Wagner H
    Int Immunol; 1993 Aug; 5(8):929-37. PubMed ID: 8398987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.